Stereotaxis (STXS) Change in Receivables (2010 - 2026)
Stereotaxis' (STXS) quarterly Change in Receivables came in at -$543000.0 in Q1 2026, down 208.6% year-over-year from $500000.0 in Q1 2025, and down 205.64% quarter-over-quarter from $514000.0 in Q4 2025.
Powered by 
Analysis
Stereotaxis (STXS) Change in Receivables (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Change in Receivables for 17 consecutive years, with -$543000.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Change in Receivables fell 208.6% year-over-year to -$543000.0 in Q1 2026; TTM through Mar 2026 was $980000.0, a 404.35% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 392.76% from the prior year.
- Change in Receivables was -$543000.0 for Q1 2026 at Stereotaxis, down from $514000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $4.4 million in Q3 2024 and troughed at -$4.1 million in Q4 2024.
- A 5-year average of -$46764.7 and a median of $13000.0 in 2022 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables sank 11053.85% in 2023 and soared 417.44% in 2024, its largest moves.
- Over 5 years, Change in Receivables stood at $13000.0 in 2022, then slumped by 11053.85% to -$1.4 million in 2023, then slumped by 187.36% to -$4.1 million in 2024, then jumped by 112.56% to $514000.0 in 2025, then slumped by 205.64% to -$543000.0 in 2026.
- The last three Change in Receivables figures came in at -$543000.0 (Q1 2026), $514000.0 (Q4 2025), and $940000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | -543,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -543,000.00 |
| Dec 31, 2025 | 514,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Jun 30, 2025 | 69,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | -4.09 Mn |
| Sep 30, 2024 | 4.44 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | 131,000.00 |
| Dec 31, 2023 | -1.42 Mn |
| Sep 30, 2023 | -1.40 Mn |
| Jun 30, 2023 | 1.77 Mn |
| Mar 31, 2023 | -216,000.00 |
| Dec 31, 2022 | 13,000.00 |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | -945,000.00 |
| Mar 31, 2022 | -713,000.00 |
| Dec 31, 2021 | 333,000.00 |
| Sep 30, 2021 | 421,000.00 |
| Jun 30, 2021 | -2.64 Mn |